Literature DB >> 30042022

PKA phosphorylation of Cav1.2 channel modulates the interaction of calmodulin with the C terminal tail of the channel.

Ming Lei1, Jianjun Xu2, Qinghua Gao1, Etsuko Minobe3, Masaki Kameyama3, Liying Hao4.   

Abstract

Activity of cardiac Cav1.2 channels is enhanced by cyclic AMP-PKA signaling. In this study, we studied the effects of PKA phosphorylation on the binding of calmodulin to the fragment peptide of the proximal C-terminal tail of α1C subunit (CT1, a.a. 1509-1789 of guinea-pig). In the pull-down assay, in vitro PKA phosphorylation significantly decreased calmodulin binding to CT1 (61%) at high [Ca2+]. The phosphoresistant (CT1SA) and phosphomimetic (CT1SD) CT1 mutants, in which three PKA sites (Ser1574, 1626, 1699) were mutated to Ala and Asp, respectively, bound with calmodulin with 99% and 65% amount, respectively, compared to that of wild-type CT1. In contrast, at low [Ca2+], calmodulin-binding to CT1SD was higher (33-35%) than that to CT1SA. The distal C-terminal region of α1C (CT3, a.a. 1942-2169) is known to interact with CT1 and inhibit channel activity. CT3 bound to CT1SD was also significantly less than that to CT1SA. In inside-out patch, PKA catalytic subunit (PKAc) facilitated Ca2+ channel activity at both high and low Ca2+ condition. Altogether, these results support the hypothesis that PKA phosphorylation may enhance channel activity and attenuate the Ca2+-dependent inactivation, at least partially, by modulating calmodulin-CT1 interaction both directly and indirectly via CT3-CT1 interaction.
Copyright © 2018 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ca(2+) channels; Calmodulin; Cav1.2; PKA; Phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 30042022     DOI: 10.1016/j.jphs.2018.05.010

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  5 in total

1.  Modeling the activity of the dopamine signaling pathway by combination of analog electrical circuit and mathematical approaches.

Authors:  A V Shumilov; P M Gotovtsev
Journal:  Heliyon       Date:  2021-01-06

2.  Negative inotropic mechanisms of β-cardiotoxin in cardiomyocytes by depression of myofilament ATPase activity without activation of the classical β-adrenergic pathway.

Authors:  Tuchakorn Lertwanakarn; Montamas Suntravat; Elda E Sánchez; Beata M Wolska; R John Solaro; Pieter P de Tombe; Kittipong Tachampa
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

3.  L-type channel inactivation balances the increased peak calcium current due to absence of Rad in cardiomyocytes.

Authors:  Brooke M Ahern; Andrea Sebastian; Bryana M Levitan; Jensen Goh; Douglas A Andres; Jonathan Satin
Journal:  J Gen Physiol       Date:  2021-07-16       Impact factor: 4.086

4.  The CaMKII phosphorylation site Thr1604 in the CaV1.2 channel is involved in pathological myocardial hypertrophy in rats.

Authors:  Jingyuan Li; Siqi Wang; Jie Zhang; Yan Liu; Xi Zheng; Fan Ding; Xuefei Sun; Meimi Zhao; Liying Hao
Journal:  Channels (Austin)       Date:  2020-12       Impact factor: 2.581

Review 5.  Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases.

Authors:  Yun Li; Hong Yang; Tianhan He; Liang Zhang; Chao Liu
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.